Anzeige
Mehr »
Login
Dienstag, 21.09.2021 Börsentäglich über 12.000 News von 674 internationalen Medien
Relay Medical – Jetzt der Durchbruch für gleich zwei Schlüsseltechnologien!?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 883035 ISIN: US8816242098 Ticker-Symbol: TEV 
Tradegate
21.09.21
13:10 Uhr
7,490 Euro
+0,080
+1,08 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
TEVA PHARMACEUTICAL INDUSTRIES LTD Chart 1 Jahr
5-Tage-Chart
TEVA PHARMACEUTICAL INDUSTRIES LTD 5-Tage-Chart
RealtimeGeldBriefZeit
7,4607,50013:20
7,4707,50013:11

Aktuelle News zur TEVA Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrTeva: Cautiously Bullish On 5-Year Prospects63
TEVA Aktie jetzt für 0€ handeln
12.09.Court denies Teva's motion to dismiss Copaxone kickbacks case87
09.09.Teva Humira biosimilar candidate demonstrates bioequivalence in switching study39
09.09.Two pharma giants claim Irish-based Teva breached its patents45
08.09.No joy for Ajovy: Teva's migraine drug can't find a win in meta-analysis versus Biohaven, AbbVie meds45
08.09.Teva: Data Shows Ajovy Reduces More Monthly Migraine Days In Study With Atogepant And Rimegepant413PETAH TIKVA (dpa-AFX) - Teva Pharmaceutical Industries Ltd. (TEVA) said that late-breaking data at the international headache society & european headache federation joint congress 2021 showed...
► Artikel lesen
08.09.Pfizer, Teva settle patent dispute over blockbuster arthritis drug Xeljanz22
07.09.Teva's pursuit of J&J boosted by FDA acceptance of filing for approval of long-acting schizophrenia drug30
01.09.Teva's (TEVA) NDA for Schizophrenia Drug Gets FDA Acceptance21
01.09.US FDA accepts Teva-MedinCell's new drug application for drug to treat schizophrenia15
01.09.Teva-MedinCell's Schizophrenia Treatment Candidate Under FDA Review14
31.08.FDA Accepts Teva, MedinCell NDA For Schizophrenia Treatment477PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), and MedinCell (MEDCL) Tuesday said that the New Drug Application for TV-46000/mdc-IRM...
► Artikel lesen
31.08.Teva's subcutaneous risperidone NDA for schizophrenia accepted by FDA14
31.08.Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia298File acceptance marks important milestone for Teva and MedinCell's commitment to treatments for mental disorders Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE...
► Artikel lesen
31.08.Teva Pharmaceutical Industries Limited: Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia360File acceptance marks important milestone for Teva's commitment to treatments for mental disorders Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE:...
► Artikel lesen
31.08.Departing Moderna CMO Tal Zaks joining Teva Pharmaceutical board16
31.08.Teva recruits Tal Zaks to its board, offering $300K+ pay package and seamless transition from Moderna28
30.08.Former Moderna CMO Zaks goes back to his Israeli roots, re-emerging as Teva board director43
28.08.Teva appoints former Moderna CMO Tal Zaks to board53
27.08.TEVA PHARMACEUTICAL INDUSTRIES LTD - 8-K, Current Report35
Seite:  Weiter >>
170 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
10,2,28